INTERNATIONAL PATENT: VAXART, INC., THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM FILES APPLICATION FOR "ANTIBODIES TARGETING GII GENOTYPES OF HUMAN NOROVIRUS"

GENEVA, Dec. 17 -- VAXART, INC. (170 Harbor Way, Suite 300South San Francisco, California 94080), THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (136 E. Rosemary Street, Suite 100Chapel Hill, North Carolina), BOARD OF REGENTS, UNIVERSITY OF TEXAS SYSTEM (210 W. 7TH StreetAustin, Texas 78701) filed a patent application (PCT/US2025/032312) for "ANTIBODIES TARGETING GII GENOTYPES OF HUMAN NOROVIRUS" on Jun 04, 2025. With publication no. WO/2025/255258, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LINDESMITH, Lisa C. (c/o...